Does Participation in a Pre-Operative Physical Activity Program Improve Patient Outcomes and Quality of Life?
An Integrated Surgical and Physical Activity Program to Identify Bariatric Surgery Quality Indicators and Evaluate Patient Outcomes and Quality of Life
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3T 2EB
- Centre for Metabolic and Bariatric Surgery (CMBS)
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male and female obese adults (Body Mass Index equal to or greater than 35 and under 55);
- over 18 years old,
- approved for publicly funded Roux-en-Y gastric bypass surgery by the Centre for Metabolic and Bariatric Surgery,
- able to attend the regular training and education sessions of the intervention program.
Exclusion Criteria:
- Exclusion criteria include any orthopedic, neurologic or cardiopulmonary conditions that preclude moderately strenuous exercise,
- Body Mass Index over 55 (super-obese),
- sleeve gastrectomy, and
- the inability to commit to attending the regular training and education sessions of the intervention program.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Control Group (Standard of Care)
All patients will receive the Centre for Metabolic and Bariatric Surgery (CMBS) standard of care including two to four multidisciplinary visits over six months, exercise counseling (kinesiologist), completion of a the CMBS behavior modification program (Craving ChangeTM), and achievement of lifestyle and dietary modification goals in order to be scheduled for surgery.
The standard of care will be used as the control group (n=24).
Matched historical controls (1:1) will be selected (based on age, gender, and body mass index) from the existing CMBS database.
|
|
|
Experimental: Intervention Group-ENCOURAGEING START
Intervention group participants (n=24) will receive the standard of care and complete a 16-week supervised physical activity/behaviour modification program at no cost.
The first eight weeks of the program involves structured exercise (two per week) and education classes that patients must attend.
Progression to a moderate/high-intensity interval program based the patient's capabilities will occur.
Participants will also attend education sessions on risk factor reduction, healthy eating, exercise, stress management and promotion of self-managed care.
During the second eight week period, participants will be given access to attend drop-in exercise classes or can opt to complete at home exercise.
Participants will have an opportunity to meet with the kinesiologist on at least 4 occasions (60 minutes/meeting) for additional physical activity counseling and assistance with overcoming barriers preventing physical activity.
|
16-week physical activity and behaviour modification/education program.
CMBS approved bariatric surgery patients participate in structured, supervised physical activity sessions (2 per week) and behaviour modification-education classes during weeks 1 through 8.
During weeks 9 through 16, patients will be given access to attend drop in physical activity sessions or can opt to complete physical activity at home.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Six Minute Walk Test (6MWT)
Time Frame: Baseline (0 weeks), 8 weeks, 16 weeks, one year.
|
Measures the distance a patient walks, unassisted and at a self-selected pace, in six minutes.
A validated measure of physical fitness and a well-established measure of functional capacity.
Has been used to measure improvements in functional capacity in pre- and post- bariatric surgery patients.
|
Baseline (0 weeks), 8 weeks, 16 weeks, one year.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anthropometric Measurements-1
Time Frame: Baseline (0 weeks), 8 weeks, 16 weeks, one and five years.
|
Height (cm)
|
Baseline (0 weeks), 8 weeks, 16 weeks, one and five years.
|
|
Anthropometric Measurements-2
Time Frame: Baseline (0 weeks), 8 weeks, 16 weeks, one and five years.
|
Body Mass Index (kg/m2)
|
Baseline (0 weeks), 8 weeks, 16 weeks, one and five years.
|
|
Anthropometric Measurements-3
Time Frame: Baseline (0 weeks), 8 weeks, 16 weeks, one and five years.
|
Neck circumference (cm)
|
Baseline (0 weeks), 8 weeks, 16 weeks, one and five years.
|
|
Anthropometric Measurements-4
Time Frame: Baseline (0 weeks), 8 weeks, 16 weeks, one and five years.
|
Waist circumference (cm)
|
Baseline (0 weeks), 8 weeks, 16 weeks, one and five years.
|
|
Anthropometric Measurements-5
Time Frame: Baseline (0 weeks), 8 weeks, 16 weeks, one and five years.
|
Hip circumference (cm)
|
Baseline (0 weeks), 8 weeks, 16 weeks, one and five years.
|
|
Anthropometric Measurements-6
Time Frame: Baseline (0 weeks), 8 weeks, 16 weeks, and one year.
|
Body composition (Bioelectric Impedance Analysis)
|
Baseline (0 weeks), 8 weeks, 16 weeks, and one year.
|
|
Anthropometric Measurements-7
Time Frame: Baseline (0 weeks), 8 weeks, 16 weeks, one and five years.
|
Weight (kg)
|
Baseline (0 weeks), 8 weeks, 16 weeks, one and five years.
|
|
Strength Measurements-1
Time Frame: Baseline (0 weeks), 8 weeks,16 weeks, and one year
|
Half-squat test (to assess dynamic balance, flexibility and muscular endurance).
|
Baseline (0 weeks), 8 weeks,16 weeks, and one year
|
|
Strength Measurements-2
Time Frame: Baseline (0 weeks), 8 weeks,16 weeks, and one year
|
Hand grip test (to assess upper limb muscle strength and dynamic muscle endurance of the biceps).
|
Baseline (0 weeks), 8 weeks,16 weeks, and one year
|
|
Strength Measurements-3
Time Frame: Baseline (0 weeks), 8 weeks,16 weeks, and one year
|
Sit to stand test (to assess dynamic balance, flexibility and muscular endurance).
|
Baseline (0 weeks), 8 weeks,16 weeks, and one year
|
|
Strength Measurements-4
Time Frame: Baseline (0 weeks), 8 weeks,16 weeks, and one year
|
Arm curl tests (to assess upper limb muscle strength and dynamic muscle endurance of the biceps).
|
Baseline (0 weeks), 8 weeks,16 weeks, and one year
|
|
Physical Activity Level
Time Frame: Baseline (0 weeks), 8 and 16 weeks; one year.
|
Measured using the Actigraph accelerometer.
Each patient will be issued an Actigraph accelerometer that will track their physical activity level.
|
Baseline (0 weeks), 8 and 16 weeks; one year.
|
|
Cardiovascular Disease Risk Measurement-1
Time Frame: Baseline (0 weeks), 8 weeks, 16 weeks and one year.
|
Blood pressure (mmHg)
|
Baseline (0 weeks), 8 weeks, 16 weeks and one year.
|
|
Cardiovascular Disease Risk Measurement-2
Time Frame: Baseline (0 weeks), 16 weeks and one year.
|
Total cholesterol
|
Baseline (0 weeks), 16 weeks and one year.
|
|
Cardiovascular Disease Risk Measurement-3
Time Frame: Baseline (0 weeks), 16 weeks and one year.
|
LDL cholesterol
|
Baseline (0 weeks), 16 weeks and one year.
|
|
Cardiovascular Disease Risk Measurement-4
Time Frame: Baseline (0 weeks), 16 weeks and one year.
|
HDL cholesterol
|
Baseline (0 weeks), 16 weeks and one year.
|
|
Cardiovascular Disease Risk Measurement-5
Time Frame: Baseline (0 weeks), 16 weeks and one year.
|
Blood triacylglyceride measurement
|
Baseline (0 weeks), 16 weeks and one year.
|
|
Cardiovascular Disease Risk Measurement-6
Time Frame: Baseline (0 weeks), 16 weeks and one year.
|
Blood glucose
|
Baseline (0 weeks), 16 weeks and one year.
|
|
Cardiovascular Disease Risk Measurement-7
Time Frame: Baseline (0 weeks), 16 weeks and one year.
|
Blood glycosylated hemoglobin (HA1c)
|
Baseline (0 weeks), 16 weeks and one year.
|
|
Cardiovascular Disease Risk Measurement-8
Time Frame: Baseline (0 weeks), 8 weeks, 16 weeks and one year.
|
Small artery elasticity
|
Baseline (0 weeks), 8 weeks, 16 weeks and one year.
|
|
Cardiovascular Disease Risk Measurement-9
Time Frame: Baseline (0 weeks), 8 weeks, 16 weeks and one year.
|
Large artery elasticity.
|
Baseline (0 weeks), 8 weeks, 16 weeks and one year.
|
|
Patient quality of life, satisfaction, and mental health-1
Time Frame: Baseline (0 weeks), 8 weeks, 16 weeks; one and five years.
|
Laval Health Related Quality of Life Questionnaire.
|
Baseline (0 weeks), 8 weeks, 16 weeks; one and five years.
|
|
Patient quality of life, satisfaction, and mental health-2
Time Frame: Baseline (0 weeks), 8 weeks, 16 weeks; one and five years.
|
Patient Satisfaction Questionnaire (PSQ-18)
|
Baseline (0 weeks), 8 weeks, 16 weeks; one and five years.
|
|
Patient quality of life, satisfaction, and mental health-3
Time Frame: Baseline (0 weeks), 8 weeks, 16 weeks; one and five years.
|
Patient Health Questionnaire (PHQ-9)
|
Baseline (0 weeks), 8 weeks, 16 weeks; one and five years.
|
|
Self-Compassion, Anxiety, and Physical Activity Questionnaires
Time Frame: Baseline (0 weeks), 8 weeks, 16 weeks; one and five years.
|
Various surveys assembled into one questionnaire package; Self-Compassion Scale, multi-dimensional Health Questionnaire (MHQ)-Health Anxiety Sub-Scale, Affective Responses to a Real Health Problem, Response to Illness Questionnaire, Physical Activity Intentions, Social Physique Anxiety Scale, Body Appreciation Scale-2, Exercise Task Self-Efficacy, and Exercise Regulations Questionnaire (BREQ-3).
|
Baseline (0 weeks), 8 weeks, 16 weeks; one and five years.
|
|
Patient quality of life, satisfaction, and mental health-4
Time Frame: Baseline (0 weeks), 8 weeks, 16 weeks; one and five years.
|
Hospital Anxiety and Depression Scale (HADS),
|
Baseline (0 weeks), 8 weeks, 16 weeks; one and five years.
|
|
Surgical Outcome Measures-1
Time Frame: one year
|
Surgical complication rate.
|
one year
|
|
Surgical Outcome Measures-2
Time Frame: one year
|
Hospital length of stay.
|
one year
|
|
Surgical Outcome Measures-3
Time Frame: one year
|
Comorbidity resolution.
|
one year
|
|
Surgical Outcome Measures-4
Time Frame: one year
|
Continued participation in physical activity.
|
one year
|
|
Surgical Outcome Measures-5
Time Frame: one year
|
Weight loss (amount; kg).
|
one year
|
|
Surgical Outcome Measures-6
Time Frame: one year
|
Weight loss maintenance.
|
one year
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Krista M Hardy, MD, MSC, FRCSC, FACS, University of Manitoba
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- H2016:283
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
NCT07378215RecruitingQuality of Life | Postoperative Quality of Recovery | Health-Related Quality-of-Life
-
NCT04239183UnknownQuality of Life of Colostomized Patient
-
NCT02901639UnknownImproving Quality of Life
-
NCT04761367CompletedImprove Quality of Life
-
NCT05722249CompletedProfessional Quality of Life
-
NCT01784497CompletedHealth Related Quality of Life
-
NCT01269489UnknownHealth-related Quality of Life
-
NCT01247636CompletedHealth-Related Quality of Life
-
NCT06014671CompletedBreif Description: Patients' Quality of Life of
Clinical Trials on ENCOURAGEING START
-
NCT03385902CompletedChronic Kidney Disease
-
NCT06336642Recruiting
-
NCT06298357Completed
-
NCT02992873CompletedOut-Of-Hospital Cardiac Arrest | Cardiac Arrest, Sudden
-
NCT06860009Not yet recruitingIBD | Ulcerative Colitis (UC) | Crohn's Diseases
-
NCT06374550Completed
-
NCT04774770RecruitingEnd Stage Renal Disease | End Stage Kidney Disease | End Stage Renal Failure on Dialysis | End Stage Renal Disease on Dialysis